Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Non-Diabetic Chronic Kidney Disease
Akira Mima
Topics & Concepts
DapagliflozinEmpagliflozinMedicineKidney diseaseDiabetes mellitusInternal medicineType 2 diabetesHeart failureRenal functionClinical endpointClinical trialEndocrinologyDiabetes Treatment and ManagementChronic Kidney Disease and DiabetesPotassium and Related Disorders